Bayer Drug Development Simulation Brings the Realities of Pharmaceutical R&D to Life
As part of the iCANPOD/iCANDOC Workshop Series: Perspectives in Precision Cancer Medicine inand Outside Academia, iCANDOC hosted the Bayer Drug…
-
-
BioFinland Pitching Competition motivated Arina Värä to develop and pitch her business idea based on her iCANDOC doctoral research project – with winning results
Arina Värä, a doctoral researcher at iCANDOC Doctoral Education Pilot in Precision Cancer Medicine studies Boron neutron capture therapy (BNCT)…
-
Opening event of the Postdoc Program iCANPOD: Inspiring talks, research highlights, and networking
The new iCANPOD postdoctoral program in Precision Cancer Medicine at the University of Helsinki was officially launched with an opening event on 26.11.2025 in Biomedicum, Helsinki. ICANPOD offers career development and…
-
News iCAN Community iCAN Flagship Project iCAN National Program iCANDOC Patient and public involvement
Mission Possible – Delivering translational impact
More than 360 participants: speakers, researchers, clinicians, patients, sponsors, and other cancer research specialists gathered in Little Finlandia (Helsinki) on…
-
Professor Satu Mustjoki awarded the 2025 iCMLf Rowley Prize
The International Chronic Myeloid Leukemia Foundation (iCMLf) has announced that Professor Satu Mustjoki, Scientific Director of the iCAN – Digital Precision…
-
New funding from Jane and Aatos Erkko Foundation accelerates cancer innovation
The Jane and Aatos Erkko Foundation has announced its latest round of research funding – a highly competitive call where…
-
Viestisi tutkijoille – Ditt budskap till forskningsgemenskapen
Mitä syöpään sairastuneena tai läheisenä haluaisit kertoa syöpätutkijalle? Mikä on se ongelma, joka sinua eniten huolettaa syöpään ja hoitoihin liittyen,…
-
New director appointed to lead the iCANDOC pilot programme
We are pleased to announce the appointment of Mariike Kuijjer, who took on the role of Director of the iCANDOC…
-
iCAN Studyathon: Advancing Real-World Treatment Insights for Lung Cancer
Our first-ever iCAN Studyathon, an initiative focused on metastatic non-small cell lung cancer (mNSCLC) and the real-life impact of immune checkpoint inhibitor (ICIs) therapy, took…
-
iCANDOC national get-together: Fostering collaboration among doctoral researchers
The first-ever iCANDOC national get-together gathered doctoral researchers and their supervisors from all five participating universities. The event provided an…
End of content
End of content